Trial Profile
Phase II study of low-dose Nab-paclitaxel for advanced breast cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2019
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 04 Feb 2019 Status changed from recruiting to discontinued.
- 18 Oct 2013 New trial record